Maxcyte (MXCT) Restructuring Costs (2025)
Maxcyte's (MXCT) quarterly Restructuring Costs came in at $3.1 million in Q3 2025.
Powered by 
Analysis
Maxcyte (MXCT) Restructuring Costs (2025) Analysis & Trends
Maxcyte (MXCT) has reported Restructuring Costs for 1 consecutive years, with $3.1 million the latest figure, recorded in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 225.12 Bn | 221.06 Bn | 8.34 Bn |
| 2 | Danaher | 144.34 Bn | 139.99 Bn | 3.61 Bn |
| 3 | Agilent Technologies | 41.01 Bn | 39.25 Bn | 1.04 Bn |
| 4 | Illumina | 31.14 Bn | 29.97 Bn | 770.00 Mn |
| 5 | Revvity | 13.89 Bn | 12.86 Bn | 416.87 Mn |
| 6 | Bio-Techne | 11.27 Bn | 11.00 Bn | 211.39 Mn |
| 7 | Bio-Rad Laboratories | 10.13 Bn | 8.51 Bn | 345.80 Mn |
| 8 | Repligen | 9.34 Bn | 8.33 Bn | 110.04 Mn |
| 9 | 10x Genomics | 8.67 Bn | 8.12 Bn | 112.50 Mn |
| 10 | Maxcyte | 132.99 Mn | 132.99 Mn | 5.60 Mn |